2022
DOI: 10.1186/s40634-022-00453-3
|View full text |Cite
|
Sign up to set email alerts
|

Neutralization of HMGB1 improves fracture healing and γδ T lymphocyte counts at the fracture site in a polytrauma rat model

Abstract: Purpose Delayed fracture healing is a common consequence of polytrauma (PT) occurring in patients with multiple injuries. We believe that when early release of high mobility group box 1 (HMGB1) molecules from necrotic tissues exceed their normal levels in blood, they dysregulate immune responses associated with normal healing. This study investigates the detrimental effect of such dysregulate immune responses by targeting HMGB1 in a PT rat model with debilitating injuries. We hypothesized that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…When this proinflammatory upstream cytokine is blocked by an HBGB1 antibody, healing is restored. 20 Importantly, blocking inflammation upstream restores RAGE and TLR4 surface expression on circulating T cells and increases the number of gdTCR 1 T cells at the fracture site. The observations provide rich potential targets for future interventions.…”
Section: Immune Dysregulation Causes Impaired Wound and Fracture Healingmentioning
confidence: 99%
“…When this proinflammatory upstream cytokine is blocked by an HBGB1 antibody, healing is restored. 20 Importantly, blocking inflammation upstream restores RAGE and TLR4 surface expression on circulating T cells and increases the number of gdTCR 1 T cells at the fracture site. The observations provide rich potential targets for future interventions.…”
Section: Immune Dysregulation Causes Impaired Wound and Fracture Healingmentioning
confidence: 99%
“…While the role of HMGB1 and S100 has been previously studied in PT patients with delayed bone healing scenarios, the role of cell free mtDNA and associated pathways are yet to be explored in the context of PT. In a previous study, we demonstrated that by transient neutralization of HMGB1 and its associated pro‐inflammatory pathways we could achieve improved bone fracture healing in a PT rat model [7]. Next, we questioned whether DAMP activated pathways, different from those activated by HMGB1, when modulated can regulate confounding immune responses and maintain proper homeostasis to promote bone healing.…”
Section: Introductionmentioning
confidence: 99%
“…[13,14] In the latest study, HMGB1 was found to promote fracture healing in rat fracture models. [15,16] However, so far, no clinical studies focus on the role of HMGB1 in intertrochanteric fracture development and prognosis.…”
Section: Introductionmentioning
confidence: 99%